Loading organizations...
Allelica: Genomics software company integrating multi-ancestry polygenic risk scores into clinical practice to predict common disease risk.
Based in New York City, Allelica is a genomics software company that develops tools and genetic tests to integrate polygenic risk scores into clinical practice for disease risk prediction. The company provides a software platform and clinical testing services to healthcare providers, laboratories, and pharmaceutical companies to identify individuals at high genetic risk for conditions like heart disease and cancer. Operating with fewer than 50 employees, the enterprise generates under $5 million in annual revenue and secured $5 million in Series A funding in 2022. Allelica is backed by investors including Valor Ventures, Sternberg Family Office, and Pi Campus, and maintains strategic partnerships with Merck and Illumina. The firm recently launched its AbsoluteDx test and secured a proprietary CPT code to facilitate clinical reimbursement. Allelica was founded in 2017 by Giordano Bottà, George Busby, and Paolo Di Cara.
Allelica has raised $1.8M across 1 funding round.
Allelica has raised $1.8M in total across 1 funding round.
Allelica has raised $1.8M in total across 1 funding round.
Allelica's investors include Pi Campus, Sternberg Health, Gary Peat.
Allelica has raised $1.8M across 1 funding round. Most recently, it raised $1.8M Seed in March 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 12, 2021 | $1.8M Seed | Pi Campus, Sternberg Health, Gary Peat |